Attached files

file filename
EX-99.2 - EX-99.2 - BAXANO SURGICAL, INC.g25967exv99w2.htm
EX-99.1 - EX-99.1 - BAXANO SURGICAL, INC.g25967exv99w1.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 2, 2011
TRANS1 INC.
(Exact name of registrant as specified in its charter)
         
Delaware
(State or other
jurisdiction of incorporation)
  001-33744
(Commission File Number)
  33-0909022
(IRS Employer Identification No.)
     
301 Government Center Drive
Wilmington, North Carolina 28403

(Address of principal executive offices)
(Zip Code)
(910) 332-1700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 7.01   Regulation FD Disclosure.
     On February 1, 2011, Trans1 Inc., a Delaware corporation (the “Company”) issued a press release to announce a conference call to provide an update on its reimbursement strategy. The release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
     On February 2, 2011, the Company conducted the conference call referred to above. A copy of the transcript of the conference call is attached as Exhibit 99.2 and is incorporated herein by reference.
     The information in this Item 7.01, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01   Financial Statements and Exhibits.
     (d) Exhibits.
         
Exhibit Number   Description
  99.1    
Press release, dated February 1, 2011.
       
 
  99.2    
Conference call transcript, dated February 2, 2011.

 


 

Signatures
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  TRANS1 INC.
 
 
February 2, 2011  By:   /s/ Joseph P. Slattery    
    Joseph P. Slattery   
    Executive Vice President and Chief Financial Officer   
 

 


 

EXHIBIT INDEX
         
Exhibit Number   Description
  99.1    
Press release, dated February 1, 2011.
       
 
  99.2    
Conference call transcript, dated February 2, 2011.